MedTrace Logo

Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

NCT05047926 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-08-08

No results posted yet for this study

Summary

This clinical trial evaluates whether a prehabilitation program started at the time of neoadjuvant chemotherapy will affect surgical recovery in patients with stage IIIC-IV ovarian, fallopian tube, or primary peritoneal cancer. A prehabilitation program may improve the quality of life after surgery for patients with ovarian, fallopian tube, or primary peritoneal cancer.

Conditions

  • Advanced Ovarian Carcinoma
  • Stage IIIC Fallopian Tube Cancer AJCC v8
  • Stage IIIC Ovarian Cancer AJCC v8
  • Stage IIIC Primary Peritoneal Cancer AJCC v8
  • Stage IV Fallopian Tube Cancer AJCC v8
  • Stage IV Ovarian Cancer AJCC v8
  • Stage IV Primary Peritoneal Cancer AJCC v8

Interventions

BEHAVIORAL

Behavioral Counseling

Undergo behavioral counseling

DIETARY_SUPPLEMENT

Nutritional Supplement Drink

Given Boost or Ensure

OTHER

Physical Activity

Complete physical activity assignments

OTHER

Survey Administration

Complete surveys

PROCEDURE

Computed Tomography

Undergo CT scans

PROCEDURE

Biospecimen Collection

Undergo blood collection

BEHAVIORAL

Health Education

Complete Resilient Living program

OTHER

Medical Device Usage and Evaluation

Wear a FitBit

Sponsors & Collaborators

Principal Investigators

  • Amanika A. Kumar, MD · Mayo Clinic in Rochester

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-05
Primary Completion
2025-07-08
Completion
2025-07-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05047926 on ClinicalTrials.gov